Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows From Operating Activities:    
Net loss $ (2,537) $ (2,990)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 101 83
Subsidiary stock issuances to vendor 0 26
Depreciation 33 58
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (42) 297
Right of use asset 39 33
Accounts payable (265) (1,068)
Accrued expenses (71) (714)
Accrued employee benefits (518) (626)
Lease liability (68) (59)
Net Cash Used In Operating Activities (3,328) (4,960)
Cash Flows From Investing Activities:    
Purchases of property and equipment (14) 0
Net Cash Used In Investing Activities (14) 0
Cash Flows From Financing Activities:    
Proceeds from "at the market" stock issuance 65,960 0
Proceeds from issuance of common stock for warrant exercises 8,042 0
Net Cash Provided By Financing Activities 74,002 0
Net increase (decrease) in cash and cash equivalents 70,660 (4,960)
Cash and cash equivalents at the beginning of this period 6,227 15,045
Cash and cash equivalents at the end of this period 76,887 10,085
NONCASH FINANCING ACTIVITIES:    
Effect of Series A Preferred Stock price adjustment 7,402 0
Conversion of Series B Preferred Stock 2,477 669
Deemed dividends for accretion of Series B Preferred Stock discount 1,497 404
In-kind dividends paid in preferred stock $ 23 $ 62